546299534	546299534	CD	B-NP	O
|	|	NN	I-NP	O
CHMH	CHMH	NN	I-NP	O
|	|	NN	I-NP	O
54433044	54433044	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
7368416	7368416	CD	B-NP	O
|	|	CC	I-NP	O
4/20/2006	4/20/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
right	right	JJ	I-NP	O
quardicept	quardicept	JJ	I-NP	O
tendon	tendon	NN	I-NP	O
rupture	rupture	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/9/2006	6/9/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/5/2006	11/5/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
READING	READING	NNP	B-NP	O
,	,	,	O	O
FILIBERTO	FILIBERTO	NNP	B-NP	O
L	L	NNP	I-NP	O
084-86-53-0	084-86-53-0	CD	I-NP	O
Dale	Dale	NNP	I-NP	O
I	I	NNP	I-NP	O
Jo	Jo	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
10/18/06	10/18/06	CD	B-NP	O
AT	AT	NN	I-NP	O
04	04	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
HAMEISTER	HAMEISTER	NNP	B-NP	O
,	,	,	O	O
NIGEL	NIGEL	NNP	B-NP	O
H.	H.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
TYLENOL	TYLENOL	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ACETAMINOPHEN	ACETAMINOPHEN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
650	650	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q4H	Q4H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Headache	Headache	NNP	I-NP	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NNP	I-NP	O
ACID	ACID	NNP	I-NP	O
81	81	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
7/7/06	7/7/06	CD	B-NP	O
by	by	IN	B-PP	O
FORM	FORM	NN	B-NP	B-protein
,	,	,	O	O
MORGAN	MORGAN	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
755918874	755918874	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/7/06	7/7/06	CD	B-NP	O
by	by	IN	B-PP	O
RODRIGUE	RODRIGUE	NNP	B-NP	O
,	,	,	O	O
LENNY	LENNY	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
0.5	0.5	CD	I-NP	O
MG	MG	NN	I-NP	O
QPM	QPM	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
361612213	361612213	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/7/06	7/7/06	CD	B-NP	O
by	by	IN	B-PP	O
CORUM	CORUM	NN	B-NP	O
,	,	,	O	O
RAYMON	RAYMON	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
655949125	655949125	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
ALLOPURINOL	ALLOPURINOL	NN	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
7/7/06	7/7/06	CD	B-NP	O
by	by	IN	B-PP	O
GUSTAVE	GUSTAVE	NN	B-NP	O
,	,	,	O	O
DUDLEY	DUDLEY	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
755918874	755918874	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ALLOPURINOL	ALLOPURINOL	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/7/06	7/7/06	CD	B-NP	O
by	by	IN	B-PP	O
DUNSWORTH	DUNSWORTH	NNP	B-NP	O
,	,	,	O	O
SAMUAL	SAMUAL	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
0.5	0.5	CD	I-NP	O
MG	MG	NN	I-NP	O
QPM	QPM	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
361612213	361612213	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ALLOPURINOL	ALLOPURINOL	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/7/06	7/7/06	CD	B-NP	O
by	by	IN	B-PP	O
FURUKAWA	FURUKAWA	NNP	B-NP	O
,	,	,	O	O
THOMAS	THOMAS	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
655949125	655949125	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ALLOPURINOL	ALLOPURINOL	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
AMIODARONE	AMIODARONE	NN	I-NP	O
200	200	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
7/7/06	7/7/06	CD	B-NP	O
by	by	IN	B-PP	O
CARRON	CARRON	NN	B-NP	O
,	,	,	O	O
SHAD	SHAD	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ZOCOR	ZOCOR	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
191679279	191679279	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
AMIODARONE	AMIODARONE	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
SIMVASTATIN	SIMVASTATIN	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/7/06	7/7/06	CD	B-NP	O
by	by	IN	B-PP	O
BAMBHROLIA	BAMBHROLIA	NN	B-NP	O
,	,	,	O	O
ANDREA	ANDREA	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
755918874	755918874	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
AMIODARONE	AMIODARONE	NNP	B-NP	O
HCL	HCL	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/7/06	7/7/06	CD	B-NP	O
by	by	IN	B-PP	O
REISENAUER	REISENAUER	NN	B-NP	O
,	,	,	O	O
BEN	BEN	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
0.5	0.5	CD	I-NP	O
MG	MG	NN	I-NP	O
QPM	QPM	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
361612213	361612213	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
AMIODARONE	AMIODARONE	NNP	B-NP	O
HCL	HCL	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/7/06	7/7/06	CD	B-NP	O
by	by	IN	B-PP	O
BLACKSHEAR	BLACKSHEAR	NN	B-NP	O
,	,	,	O	O
WARD	WARD	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
655949125	655949125	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
AMIODARONE	AMIODARONE	NNP	B-NP	O
HCL	HCL	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/7/06	7/7/06	CD	B-NP	O
by	by	IN	B-PP	O
SALVIEJO	SALVIEJO	NN	B-NP	B-protein
,	,	,	O	O
MAXWELL	MAXWELL	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
AMIODARONE	AMIODARONE	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
239208983	239208983	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
PROBABLE	PROBABLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
IV	IV	CD	B-NP	O
Contrast	Contrast	NN	I-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
Unknown	Unknown	JJ	B-ADJP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
CEFPODOXIME	CEFPODOXIME	NN	I-NP	O
PROXETIL	PROXETIL	NN	I-NP	O
200	200	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
X	X	SYM	B-NP	O
2	2	CD	I-NP	O
doses	dose	NNS	I-NP	O
Food/Drug	Food/Drug	NN	I-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
Give	Give	NN	I-NP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
COLCHICINE	COLCHICINE	NN	I-NP	O
0.6	0.6	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
EVERY	EVERY	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DAY	DAY	NNP	I-NP	O
VITAMIN	VITAMIN	NNP	I-NP	O
B12	B12	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
CYANOCOBALAMIN	CYANOCOBALAMIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
100	100	CD	I-NP	O
MCG	MCG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
10	10	CD	B-NP	O
COLACE	COLACE	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DOCUSATE	DOCUSATE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
FOLATE	FOLATE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FOLIC	FOLIC	NNP	I-NP	O
ACID	ACID	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1	1	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
LASIX	LASIX	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
FUROSEMIDE	FUROSEMIDE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
80	80	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
LASIX	LASIX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
K-DUR	K-DUR	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
KCL	KCL	NNP	I-NP	O
SLOW	SLOW	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MEQ	MEQ	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
As	As	IN	B-PP	O
per	per	IN	B-PP	O
RCH	RCH	NN	B-NP	O
Potassium	Potassium	NN	I-NP	O
Chloride	Chloride	NN	I-NP	O
Policy	Policy	NN	I-NP	O
:	:	:	O	O
each	each	DT	B-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
dose	dose	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
given	give	VBN	I-VP	O
with	with	IN	B-PP	O
4	4	CD	B-NP	O
oz	oz	NN	I-NP	O
of	of	IN	B-PP	O
fluid	fluid	NN	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
7/7/06	7/7/06	CD	B-NP	O
by	by	IN	B-PP	O
CARRABINE	CARRABINE	NN	B-NP	O
,	,	,	O	O
HANS	HANS	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
DIOVAN	DIOVAN	NNP	B-NP	O
PO	PO	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
QD	QD	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
368600938	368600938	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
VALSARTAN	VALSARTAN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/7/06	7/7/06	CD	B-NP	O
by	by	IN	B-PP	O
WOLFENBARGER	WOLFENBARGER	NN	B-NP	O
,	,	,	O	O
RALPH	RALPH	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
VALSARTAN	VALSARTAN	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
MILK	MILK	NN	I-NP	O
OF	OF	IN	B-PP	O
MAGNESIA	MAGNESIA	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
MAGNESIUM	MAGNESIUM	NNP	I-NP	O
HYDROXIDE	HYDROXIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
30	30	CD	I-NP	O
MILLILITERS	MILLILITERS	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Constipation	Constipation	NNP	I-NP	O
TOPROL	TOPROL	NNP	I-NP	O
XL	XL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
SUCCINATE	SUCCINATE	NNP	I-NP	O
EXTENDED	EXTENDED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
50	50	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Number	Number	NN	B-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
10	10	CD	B-NP	O
PRILOSEC	PRILOSEC	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OMEPRAZOLE	OMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
OXYCODONE	OXYCODONE	NNP	I-NP	O
5-10	5-10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q4H	Q4H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/17/06	7/17/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
OXYCODONE	OXYCODONE	NN	B-NP	O
PO	PO	NN	I-NP	O
5-10	5-10	CD	I-NP	O
MG	MG	NN	I-NP	O
Q4H	Q4H	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
146262232	146262232	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
PROBABLE	PROBABLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
Codeine	Codeine	NN	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
nausea	nausea	NN	B-NP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
7/7/06	7/7/06	CD	B-NP	O
by	by	IN	B-PP	O
FRAZZANO	FRAZZANO	NN	B-NP	O
,	,	,	O	O
CLINTON	CLINTON	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
OXYCODONE	OXYCODONE	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
981815711	981815711	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
PROBABLE	PROBABLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
Codeine	Codeine	NN	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
nausea	nausea	NN	B-NP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
SENNA	SENNA	NN	I-NP	O
TABLETS	TABLETS	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
SENNOSIDES	SENNOSIDES	NN	I-NP	B-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
2	2	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
ZOCOR	ZOCOR	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
SIMVASTATIN	SIMVASTATIN	NN	I-NP	I-protein
-RRB-	-RRB-	,	O	O
40	40	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BEDTIME	BEDTIME	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	O
instructs	instruct	NNS	I-NP	O
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/7/06	7/7/06	CD	B-NP	O
by	by	IN	B-PP	O
LEGRANT	LEGRANT	NNP	B-NP	O
,	,	,	O	O
MARY	MARY	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
AMIODARONE	AMIODARONE	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
SIMVASTATIN	SIMVASTATIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
SIMVASTATIN	SIMVASTATIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
SIMVASTATIN	SIMVASTATIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
DETROL	DETROL	NN	I-NP	O
LA	LA	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
TOLTERODINE	TOLTERODINE	NN	I-NP	O
TARTRATE	TARTRATE	NN	I-NP	O
LONG	LONG	NN	I-NP	O
ACTING	ACTING	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
2	2	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
10	10	CD	B-NP	O
DIOVAN	DIOVAN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
VALSARTAN	VALSARTAN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/7/06	7/7/06	CD	B-NP	O
by	by	IN	B-PP	O
ALBERY	ALBERY	NNP	B-NP	O
,	,	,	O	O
ELTON	ELTON	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
VALSARTAN	VALSARTAN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
Override	Override	NN	I-NP	O
Notice	Notice	NNP	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
7/7/06	7/7/06	CD	B-NP	O
by	by	IN	B-PP	O
DARRIGO	DARRIGO	NN	B-NP	O
,	,	,	O	O
LAMAR	LAMAR	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
K-DUR	K-DUR	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
395458747	395458747	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
VALSARTAN	VALSARTAN	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
10	10	CD	B-NP	O
COUMADIN	COUMADIN	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
ROUTINE	ROUTINE	NNP	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Standard	Standard	NNP	I-NP	O
Admin	Admin	NNP	I-NP	O
Time	Time	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
take	take	VB	B-VP	O
5mg	5mg	NN	B-NP	O
on	on	IN	B-PP	O
monday/wednesday/friday	monday/wednesday/friday	NN	B-NP	O
and	and	CC	O	O
2.5	2.5	CD	B-NP	O
mg	mg	NN	I-NP	O
on	on	IN	B-PP	O
tues/thursday/saturday	tues/thursday/saturday	NN	B-NP	O
/	/	SYM	I-NP	O
sunday	sunday	NN	I-NP	O
Food/Drug	Food/Drug	NN	I-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
No	No	DT	B-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/18/06	10/18/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
AMIODARONE	AMIODARONE	NNP	B-NP	O
HCL	HCL	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ALLOPURINOL	ALLOPURINOL	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
weight	weight	NN	B-NP	O
bearing	bear	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-VP	O
on	on	IN	B-PP	O
right	right	JJ	B-NP	O
knee	knee	NN	I-NP	O
,	,	,	O	O
knee	knee	NN	B-NP	O
immobilizer	immobilizer	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
worn	wear	VBN	I-VP	O
at	at	IN	B-PP	O
all	all	DT	B-NP	O
times	time	NNS	I-NP	O
when	when	WRB	B-ADVP	O
walking	walk	VBG	B-VP	O
.	.	.	O	O

FOLLOW	FOLLOW	NNP	B-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Moffa	Moffa	NNP	I-NP	O
orthopedics	orthopedic	NNS	I-NP	O
-	-	HYPH	B-NP	O
will	will	MD	B-VP	O
call	call	VB	I-VP	O
you	you	PRP	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
date	date	NN	I-NP	O
of	of	IN	B-PP	O
your	your	PRP$	B-NP	O
surgery	surgery	NN	I-NP	O
.	.	.	O	O

,	,	,	O	O
Follow	Follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Bakke	Bakke	NNP	I-NP	O
after	after	IN	B-SBAR	O
you	you	PRP	B-NP	O
have	have	VBP	B-VP	O
surgery	surgery	NN	B-NP	O
.	.	.	O	O

,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
2/26/06	2/26/06	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
7	7	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Sisca	Sisca	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
:	:	:	O	O
THIOPENTAL	THIOPENTAL	NN	B-NP	O
SODIUM	SODIUM	NN	I-NP	O
,	,	,	O	O
Codeine	Codeine	NN	B-NP	O
,	,	,	O	O
IV	IV	CD	B-NP	O
Contrast	Contrast	NN	I-NP	O
,	,	,	O	O
METHYLDOPA	METHYLDOPA	NN	B-NP	O
,	,	,	O	O
AMITRIPTYLINE	AMITRIPTYLINE	NN	B-NP	O
HCL	HCL	NN	I-NP	O
,	,	,	O	O
AMITRIPTYLINE	AMITRIPTYLINE	NN	B-NP	O
,	,	,	O	O
LISINOPRIL	LISINOPRIL	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
right	right	JJ	B-NP	O
knee	knee	NN	I-NP	O
pain	pain	NN	I-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
right	right	JJ	I-NP	O
quardicept	quardicept	NN	I-NP	O
tendon	tendon	NN	I-NP	O
rupture	rupture	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
CHF	CHF	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Afib	Afib	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Decubitus	Decubitus	NNP	I-NP	O
ulcers	ulcer	NNS	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
decubitus	decubitus	NN	I-NP	O
ulcer	ulcer	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
HTN	HTN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
h/o	h/o	NN	I-NP	O
Septic	Septic	JJ	I-NP	O
arthritis	arthritis	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
H/O	H/O	NN	I-NP	O
septic	septic	JJ	I-NP	O
arthritis	arthritis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
B	B	NN	I-NP	O
TKR	TKR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
S/P	S/P	NN	I-NP	O
total	total	JJ	I-NP	O
knee	knee	NN	I-NP	O
replacement	replacement	NN	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Gout	Gout	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
gout	gout	VBD	B-VP	O
-RRB-	-RRB-	NNP	B-NP	O
Chronic	Chronic	NNP	I-NP	O
vaginal	vaginal	JJ	I-NP	O
bleed	bleed	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
dysfunctional	dysfunctional	JJ	I-NP	O
uterine	uterine	JJ	I-NP	O
bleeding	bleeding	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
CCY	CCY	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
S/P	S/P	NN	I-NP	O
cholecystectomy	cholecystectomy	NN	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Morbid	Morbid	NNP	I-NP	O
obesity	obesity	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
obesity	obesity	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
cc	cc	NN	B-NP	O
:	:	:	O	O
R	R	NN	B-NP	O
knee	knee	NN	I-NP	O
pain	pain	NN	I-NP	O
--	--	:	O	O
--	--	:	O	O
-	-	HYPH	B-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
80	80	CD	B-NP	O
F	F	NN	I-NP	O
w/gout	w/gout	NN	I-NP	O
,	,	,	O	O
OA	OA	NN	B-NP	O
s/p	s/p	NN	I-NP	O
bilateral	bilateral	JJ	I-NP	O
knee	knee	NN	I-NP	O
replacement	replacement	NN	I-NP	O
in	in	IN	B-PP	O
1992	1992	CD	B-NP	O
,	,	,	O	O
admitted	admit	VBN	B-VP	O
with	with	IN	B-PP	O
acute	acute	JJ	B-ADJP	O
on	on	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
R	R	NN	I-NP	O
knee	knee	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Day	Day	NN	B-NP	O
of	of	IN	B-PP	O
admit	admit	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
tried	try	VBD	B-VP	O
to	to	TO	I-VP	O
get	get	VB	I-VP	O
up	up	RP	B-PRT	O
to	to	TO	B-VP	O
walk	walk	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
bathroom	bathroom	NN	I-NP	O
,	,	,	O	O
felt	feel	VBD	B-VP	O
acute	acute	JJ	B-NP	O
sharp	sharp	JJ	I-NP	O
pain	pain	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
R.	R.	NNP	I-NP	O
knee	knee	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
ambulate	ambulate	VB	I-VP	O
.	.	.	O	O

C/o	C/o	NN	B-NP	O
radiation	radiation	NN	I-NP	O
into	into	IN	B-PP	O
posterior	posterior	JJ	B-NP	O
knee	knee	NN	I-NP	O
;	;	:	O	O
denies	deny	VBZ	B-VP	O
any	any	DT	B-NP	O
trauma	trauma	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
ED	ED	NN	B-NP	O
,	,	,	O	O
afebrile	afebrile	NN	B-NP	O
,	,	,	O	O
VSS	VSS	NN	B-NP	B-protein
,	,	,	O	O
knee	knee	NN	B-NP	O
noted	note	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
mildly	mildly	RB	I-VP	O
swollen	swell	VBN	I-VP	O
and	and	CC	O	O
focally	focally	RB	B-NP	O
tender	tender	NN	I-NP	O
.	.	.	O	O

Had	Had	NNP	B-NP	O
R.	R.	NNP	I-NP	O
knee	knee	NN	I-NP	O
films	film	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
joint	joint	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
,	,	,	O	O
lateral	lateral	JJ	B-NP	O
subluxation	subluxation	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
patella	patella	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
fracture	fracture	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
intact	intact	JJ	B-NP	O
prosthetic	prosthetic	JJ	I-NP	O
hardware	hardware	NN	I-NP	O
.	.	.	O	O

Seen	Seen	NN	B-NP	O
by	by	IN	B-PP	O
ortho	ortho	JJ	B-NP	O
service	service	NN	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
felt	feel	VBD	B-VP	O
that	that	DT	B-NP	O
joint	joint	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
septic	septic	JJ	B-NP	O
,	,	,	I-NP	O
recommended	recommended	JJ	I-NP	O
pain	pain	NN	I-NP	O
control	control	NN	I-NP	O
and	and	CC	O	O
discharge	discharge	VB	B-VP	O
home	home	NN	B-ADVP	O
with	with	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
ortho	ortho	JJ	I-NP	O
follow-up	follow-up	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
PT	PT	NN	B-NP	O
service	service	NN	I-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
walk	walk	VB	I-VP	O
with	with	IN	B-PP	O
walker	walker	NN	B-NP	O
and	and	CC	I-NP	O
assistance	assistance	NN	I-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
recommended	recommend	VBD	B-VP	O
rehab	rehab	NN	B-NP	O
placement	placement	NN	I-NP	O
but	but	CC	O	O
refused	refuse	VBD	B-VP	O
and	and	CC	I-VP	O
agreed	agree	VBD	I-VP	O
to	to	TO	B-PP	O
inpatient	inpatient	JJ	B-NP	O
admission	admission	NN	I-NP	O
at	at	IN	B-PP	O
RH	RH	NN	B-NP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
baseline	baseline	NN	B-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
is	be	VBZ	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
walk	walk	VB	I-VP	O
~	~	NN	B-NP	O
30	30	CD	B-NP	O
feet	foot	NNS	I-NP	O
with	with	IN	B-PP	O
walker	walker	NN	B-NP	O
or	or	CC	I-NP	O
cane	cane	NN	I-NP	O
,	,	,	O	O
limited	limit	VBN	B-VP	O
by	by	IN	B-PP	O
diffuse	diffuse	JJ	B-NP	O
back	back	NN	I-NP	O
and	and	CC	I-NP	O
knee	knee	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

--	--	:	O	O
--	--	:	O	O
-	-	:	O	O
PMH	PMH	NN	B-NP	O
:	:	:	O	O
HTN	HTN	NN	B-NP	B-protein
;	;	:	O	O
AF	AF	NN	B-NP	O
,	,	,	O	O
gout	gout	NN	B-NP	O
,	,	,	O	O
OA	OA	NN	B-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
lower	low	JJR	I-NP	O
and	and	CC	I-NP	O
upper	upper	JJ	I-NP	O
back	back	JJ	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
bilateral	bilateral	JJ	B-NP	O
knee	knee	NN	I-NP	O
pain	pain	NN	I-NP	O
;	;	:	O	O
s/p	s/p	NN	B-NP	O
bilateral	bilateral	JJ	I-NP	O
knee	knee	NN	I-NP	O
replacement	replacement	NN	I-NP	O
in	in	IN	B-PP	O
1992	1992	CD	B-NP	O
;	;	:	O	O
carpal	carpal	JJ	B-NP	O
tunnel	tunnel	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
--	--	:	O	O
--	--	:	O	O
-	-	HYPH	B-NP	O
Meds	Med	NNS	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
:	:	:	O	O
ASA	ASA	NN	B-NP	O
81mg	81mg	NN	I-NP	O
daily	daily	JJ	B-ADJP	O
;	;	:	O	O
Toprol	Toprol	NNP	B-NP	O
XL	XL	NNP	I-NP	O
50mg	50mg	CD	I-NP	O
daily	daily	RB	I-NP	O
;	;	:	O	O
amiodarone	amiodarone	NN	B-NP	O
200mg	200mg	CD	I-NP	O
daily	daily	RB	B-ADVP	O
;	;	:	O	O
diovan	diovan	NN	B-NP	O
40mg	40mg	NN	I-NP	O
daily	daily	JJ	B-ADJP	O
;	;	:	O	O
zocor	zocor	NN	B-NP	O
40mg	40mg	NN	I-NP	O
qHS	qHS	NN	I-NP	O
;	;	:	O	O
NTG	NTG	NN	B-NP	O
0.4	0.4	CD	I-NP	O
mg	mg	NN	I-NP	O
tab	tab	NN	I-NP	O
SL	SL	NN	I-NP	O
prn	prn	NN	I-NP	O
;	;	:	O	O
lasix	lasix	CD	B-NP	O
80mg	80mg	CD	I-NP	O
PO	PO	NN	I-NP	O
qAM/40mg	qAM/40mg	NN	I-NP	O
PO	PO	NN	I-NP	O
qPM	qPM	NN	I-NP	O
;	;	:	O	O
K-dur	K-dur	NN	B-NP	O
20mEq	20mEq	NN	I-NP	O
bid	bid	NN	I-NP	O
;	;	:	O	O
prilosec	prilosec	NN	B-NP	O
20mg	20mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
;	;	:	O	O
folate	folate	JJ	B-NP	O
1mg	1mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
;	;	:	O	O
vitamin	vitamin	NN	B-NP	O
B12	B12	NN	I-NP	O
;	;	:	O	O
allopurinol	allopurinol	NN	B-NP	O
100mg	100mg	NN	I-NP	O
daily	daily	JJ	B-ADJP	O
;	;	:	O	O
colchicine	colchicine	NN	B-NP	O
0.6	0.6	CD	I-NP	O
mg	mg	NN	I-NP	O
qod	qod	NN	I-NP	O
;	;	:	O	O
detrol	detrol	NN	B-NP	O
LA	LA	NN	I-NP	O
4mg	4mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
prn	prn	NN	I-NP	O
;	;	:	O	O
ibuprofen	ibuprofen	NN	B-NP	B-protein
800mg	800mg	NN	I-NP	I-protein
tid	tid	NN	I-NP	I-protein
prn	prn	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
takes	take	VBZ	B-VP	O
almost	almost	RB	B-NP	O
daily	daily	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
;	;	:	O	O
allegra	allegra	NN	B-NP	O
180mg	180mg	CD	I-NP	O
daily	daily	JJ	I-NP	O
prn	prn	NN	I-NP	O
;	;	:	O	O
vicodin	vicodin	NN	B-NP	O
2mg	2mg	NN	I-NP	O
qAM/1mg	qAM/1mg	NN	I-NP	O
qPM	qPM	NN	I-NP	O
prn	prn	NN	I-NP	O
wrist	wrist	NN	I-NP	O
pain	pain	NN	I-NP	O
--	--	:	O	O
--	--	:	O	O
-	-	:	O	O
Allergies	Allergy	NNPS	B-NP	O
:	:	:	O	O
thiopental	thiopental	NN	B-NP	O
-	-	HYPH	O	O
hypertension	hypertension	NN	B-NP	O
;	;	:	O	O
codeine	codeine	NN	B-NP	O
-	-	HYPH	I-NP	O
nausea	nausea	NN	I-NP	O
;	;	:	O	O
IV	IV	CD	B-NP	O
contrast	contrast	NN	I-NP	O
,	,	,	O	O
methyldopa	methyldopa	NN	B-NP	O
-	-	HYPH	B-ADJP	O
unknown	unknown	JJ	I-ADJP	O
;	;	:	O	O
amitriptyline	amitriptyline	NN	B-NP	O
-	-	HYPH	I-NP	O
lip	lip	NN	I-NP	O
droop	droop	NN	I-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
-	-	HYPH	B-NP	O
cough	cough	NN	I-NP	O
--	--	:	O	O
--	--	:	O	O
-	-	HYPH	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
Exam	Exam	NN	I-NP	O
:	:	:	O	O
96.1	96.1	CD	B-NP	O
,	,	,	I-NP	O
97	97	CD	I-NP	O
,	,	,	I-NP	O
143/103	143/103	CD	I-NP	O
,	,	,	I-NP	O
16	16	CD	I-NP	O
,	,	,	I-NP	O
100	100	CD	I-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
Gen	Gen	NN	I-NP	O
:	:	:	O	O
NAD	NAD	NN	B-NP	O
,	,	,	O	O
obese	obese	NN	B-NP	O
,	,	,	O	O
pleasant	pleasant	NN	B-NP	O
Pulm	Pulm	NNP	I-NP	O
:	:	:	O	O
clear	clear	JJ	B-NP	O
,	,	,	I-NP	O
distant	distant	JJ	I-NP	O
lungs	lung	NNS	I-NP	O
CV	CV	NN	I-NP	O
:	:	:	O	O
irregular	irregular	JJ	B-NP	O
,	,	,	I-NP	O
tachy	tachy	JJ	I-NP	O
,	,	,	I-NP	O
distant	distant	JJ	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
clear	clear	JJ	I-NP	O
m/r/gs	m/r/g	NNS	I-NP	O
Abd	Abd	NN	I-NP	O
:	:	:	O	O
soft	soft	JJ	B-NP	O
,	,	,	I-NP	O
obese	obese	JJ	I-NP	O
,	,	,	I-NP	O
slightly	slightly	RB	I-NP	O
firm	firm	JJ	I-NP	O
,	,	,	I-NP	O
NT	NT	NN	I-NP	O
,	,	,	I-NP	O
+	+	JJ	I-NP	O
nl	nl	NN	I-NP	O
BS	BS	NNP	I-NP	O
Extr	Extr	NNP	I-NP	O
:	:	:	O	O
warm	warm	NN	B-NP	O
,	,	,	O	O
1-2	1-2	NN	B-NP	O
+	+	SYM	O	O
edema	edema	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
to	to	TO	B-PP	O
thighs	thigh	NNS	B-NP	O
,	,	,	O	O
R.	R.	NNP	B-NP	O
knee	knee	VBP	B-VP	O
not	not	RB	O	O
warm	warm	JJ	B-NP	O
,	,	,	I-NP	O
+	+	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
small	small	JJ	I-NP	O
areas	area	NNS	I-NP	O
of	of	IN	B-PP	O
point	point	NN	B-NP	O
tenderness	tenderness	NN	I-NP	O
inferior	inferior	JJ	B-ADJP	O
to	to	TO	B-PP	O
patella	patella	NN	B-NP	O
in	in	IN	B-PP	O
midline	midline	NN	B-NP	O
of	of	IN	B-PP	O
knee	knee	NN	B-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
popliteal	popliteal	JJ	B-NP	O
fossa	fossa	NN	I-NP	O
;	;	:	O	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
flex	flex	VB	I-VP	O
~	~	NN	B-NP	O
90	90	CD	B-NP	O
degrees	degree	NNS	I-NP	O
and	and	CC	O	O
extend	extend	VBP	B-VP	O
fully	fully	RB	B-ADVP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
pain	pain	NN	I-NP	O
--	--	:	O	O
--	--	:	O	O
-	-	HYPH	B-NP	O
Notable	Notable	JJ	I-NP	B-protein
Labs	Lab	NNS	I-NP	I-protein
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
:	:	:	O	O
WBC	WBC	NN	B-NP	B-DNA
5.61	5.61	CD	I-NP	I-DNA
,	,	,	O	O
%	%	NN	B-NP	O
POLY-A	POLY-A	NN	I-NP	O
66.5	66.5	CD	I-NP	O
,	,	,	O	O
ESR	ESR	NNP	B-NP	O
16	16	CD	I-NP	O
--	--	:	O	O
--	--	:	O	O
-	-	HYPH	B-NP	O
ASSESSMENT/PLAN	ASSESSMENT/PLAN	NN	I-NP	O
:	:	:	O	O
:	:	:	O	O
80F	80F	NN	B-NP	O
w/hx	w/hx	NN	I-NP	O
gout	gout	NN	I-NP	O
,	,	,	O	O
OA	OA	NN	B-NP	O
s/p	s/p	NN	I-NP	O
bilateral	bilateral	JJ	I-NP	O
knee	knee	NN	I-NP	O
replacement	replacement	NN	I-NP	O
in	in	IN	B-PP	O
1992	1992	CD	B-NP	O
,	,	,	O	O
admitted	admit	VBN	B-VP	O
with	with	IN	B-PP	O
atraumatic	atraumatic	JJ	B-NP	O
acute	acute	JJ	I-NP	O
on	on	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
R.	R.	NNP	I-NP	O
knee	knee	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Inability	Inability	NN	B-NP	O
to	to	TO	B-VP	O
extend	extend	VB	I-VP	O
rt	rt	NN	B-NP	O
knee	knee	NN	I-NP	O
c/w	c/w	NN	I-NP	O
w/quadriceps	w/quadricep	VBZ	B-VP	O
extensor	extensor	NN	B-NP	O
tendon	tendon	NN	I-NP	O
rupture	rupture	NN	I-NP	O
per	per	IN	B-PP	O
ortho	ortho	NN	B-NP	O
.	.	.	O	O

--	--	:	O	O
--	--	:	O	O
-	-	HYPH	B-NP	O
HOSPITAL	HOSPITAL	NN	I-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

ORTHO	ORTHO	NN	B-NP	B-protein
:	:	:	O	O
Pt	Pt	NN	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
quadriceps	quadricep	NNS	I-NP	O
extensor	extensor	NN	I-NP	O
tendon	tendon	NN	I-NP	O
rupture	rupture	NN	I-NP	O
by	by	IN	B-PP	O
exam	exam	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
additional	additional	JJ	I-NP	O
imaging	imaging	NN	I-NP	O
required	require	VBN	B-VP	O
.	.	.	O	O

Ortho	Ortho	NNP	B-NP	O
consulted	consult	VBD	B-VP	O
and	and	CC	I-VP	O
recommended	recommend	VBD	I-VP	O
surgical	surgical	JJ	B-NP	O
repair	repair	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
kept	keep	VBN	I-VP	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
in	in	IN	B-PP	O
anticipation	anticipation	NN	B-NP	O
of	of	IN	B-PP	O
tendon	tendon	NN	B-NP	O
repair	repair	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
could	could	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
scheduled	schedule	VBN	I-VP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
week	week	NN	I-NP	O
so	so	RB	B-ADVP	O
was	be	VBD	B-VP	O
d/c	d/c	NN	B-NP	O
'd	'd	POS	B-NP	O
home	home	NN	I-NP	O
.	.	.	O	O

Dr.	Dr.	NNP	B-NP	O
Massed	Massed	NNP	I-NP	O
will	will	MD	B-VP	O
notify	notify	VB	I-VP	O
patient	patient	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
date	date	NN	I-NP	O
of	of	IN	B-PP	O
surgery	surgery	NN	B-NP	O
.	.	.	O	O

Physical	Physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
fit	fit	NN	I-NP	O
pt	pt	NN	I-NP	O
for	for	IN	B-PP	O
brace	brace	NN	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Krumenauer	Krumenauer	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
WBAT	WBAT	NN	B-NP	O
to	to	TO	B-PP	O
R	R	NN	B-NP	O
knee	knee	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
cleared	clear	VBN	I-VP	O
by	by	IN	B-PP	O
PT	PT	NN	B-NP	O
for	for	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

Home	Home	NN	B-NP	O
PT	PT	NN	I-NP	O
arranged	arrange	VBN	B-VP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	B-protein
given	give	VBN	I-NP	I-protein
oxycodone	oxycodone	NN	I-NP	I-protein
prn	prn	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
*	*	SYM	B-NP	O
Isch	Isch	NN	I-NP	O
:	:	:	O	O
cont	cont	NN	B-NP	O
'd	'd	MD	B-VP	O
ASA	ASA	NNP	B-NP	O
.	.	.	O	O

Toprol	Toprol	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Zocor	Zocor	NNP	B-NP	O
.	.	.	O	O

*	*	SYM	B-NP	O
Pump	Pump	NN	I-NP	O
:	:	:	O	O
cont	cont	NN	B-NP	O
'd	'd	MD	O	O
diovan	diovan	NN	B-NP	O
and	and	CC	I-NP	O
lasix	lasix	NN	I-NP	O
*	*	SYM	B-NP	O
Rhythm	Rhythm	NN	I-NP	O
:	:	:	O	O
hx	hx	NN	B-NP	O
AF-RVR	AF-RVR	NN	I-NP	O
,	,	,	O	O
currently	currently	RB	B-ADVP	O
AF	AF	NN	B-NP	O
w/rate	w/rate	NN	I-NP	O
in	in	IN	B-PP	O
90s	90s	CD	B-NP	O
Cont	Cont	NNP	I-NP	O
'd	'd	POS	B-NP	O
amiodarone	amiodarone	NN	I-NP	O
200mg	200mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
held	hold	VBD	B-VP	O
2/2	2/2	CD	B-NP	O
possible	possible	JJ	I-NP	O
surgery	surgery	NN	I-NP	O
but	but	CC	O	O
restarted	restart	VBD	B-VP	O
when	when	WRB	B-ADVP	O
surgery	surgery	NN	B-NP	O
could	could	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
scheduled	schedule	VBN	I-VP	O
.	.	.	O	O

Dr.	Dr.	NNP	B-NP	O
Colestock	Colestock	NNP	I-NP	O
will	will	MD	B-VP	O
notify	notify	VB	I-VP	O
patient	patient	NN	B-NP	O
when	when	WRB	B-ADVP	O
to	to	TO	B-VP	O
stop	stop	VB	I-VP	O
coumadin	coumadin	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

RENAL	RENAL	NN	B-NP	O
:	:	:	O	O
Baseline	Baseline	NN	B-NP	O
cr	cr	NN	I-NP	O
is	be	VBZ	B-VP	O
1.7-1	1.7-1	CD	B-NP	O
.8	.8	CD	I-NP	O
.	.	.	O	O

Cr	Cr	NN	B-NP	O
increased	increase	VBD	B-VP	O
to	to	TO	B-PP	O
2.0	2.0	CD	B-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
Calc	Calc	NN	I-NP	B-protein
cr	cr	NN	I-NP	I-protein
cl	cl	NN	I-NP	I-protein
=	=	SYM	B-VP	I-protein
17	17	CD	B-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
during	during	IN	B-PP	O
admit	admit	NN	B-NP	O
.	.	.	O	O

Suspect	Suspect	NN	B-NP	O
Ibuprofen	Ibuprofen	NN	I-NP	O
as	as	IN	B-PP	O
cause	cause	NN	B-NP	O
so	so	RB	B-NP	O
d/c	d/c	NN	I-NP	O
'd	'd	MD	B-VP	O
.	.	.	O	O

Cr	Cr	NNP	B-NP	O
imprived	imprive	VBD	B-VP	O
to	to	TO	B-PP	O
1.9	1.9	CD	B-NP	O
at	at	IN	B-PP	O
d/c	d/c	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

ID	ID	NN	B-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
found	find	VBN	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
UTI	UTI	NNP	B-NP	O
.	.	.	O	O

Urine	Urine	NN	B-NP	O
culture	culture	NN	I-NP	O
grew	grow	VBD	B-VP	O
>	>	SYM	B-NP	O
100	100	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
E.	E.	NNP	I-NP	O
Coli	Coli	NNP	I-NP	O
sensitive	sensitive	JJ	B-ADJP	O
to	to	TO	B-PP	O
CXT	CXT	NN	B-NP	B-protein
.	.	.	O	O

Pt	Pt	NN	B-NP	O
given	give	VBN	B-PP	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
CXT	CXT	NN	B-NP	B-protein
and	and	CC	O	O
sent	send	VBD	B-VP	O
home	home	NN	B-ADVP	O
on	on	IN	B-PP	O
cefpodoxime	cefpodoxime	NN	B-NP	B-DNA
x	x	SYM	B-NP	I-DNA
1	1	CD	I-NP	I-DNA
more	more	JJR	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

MISC	MISC	NN	B-NP	O
:	:	:	O	O
*	*	SYM	B-NP	O
Cont	Cont	NNP	B-NP	O
'd	'd	NNP	I-NP	O
Allopurinol	Allopurinol	NNP	I-NP	O
,	,	,	O	O
Colchicine	Colchicine	NNP	B-NP	O
,	,	,	O	O
PPI	PPI	NNP	B-NP	O
,	,	,	O	O
B12	B12	NN	B-NP	B-protein
,	,	,	O	O
Folate	Folate	NN	B-NP	O
,	,	,	O	O
K-dur	K-dur	NN	B-NP	O
*	*	SYM	I-NP	O
Detrol	Detrol	NN	I-NP	O
LA	LA	NN	I-NP	O
dose	dose	NN	I-NP	O
reduced	reduce	VBN	B-VP	O
from	from	IN	B-PP	O
4	4	CD	B-NP	O
to	to	TO	B-PP	O
2mg	2mg	CD	B-NP	O
daily	daily	RB	B-ADVP	O
due	due	JJ	B-PP	O
to	to	TO	B-PP	O
reduced	reduce	VBN	B-NP	O
cr	cr	NN	I-NP	O
clearance	clearance	NN	I-NP	O
.	.	.	O	O

*	*	SYM	O	O
Code	Code	NN	B-NP	O
:	:	SYM	O	O
FULL	FULL	NN	B-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

Take	Take	VB	B-VP	O
oxycodone	oxycodone	NN	B-NP	O
5-10mg	5-10mg	:	O	O
every	every	DT	B-NP	O
4	4	CD	I-NP	O
hours	hour	NNS	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
knee	knee	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Make	Make	VB	B-VP	O
sure	sure	JJ	B-ADJP	O
you	you	PRP	B-NP	O
are	be	VBP	B-VP	O
also	also	RB	I-VP	O
taking	take	VBG	I-VP	O
colace	colace	NN	B-NP	O
100mg	100mg	NN	I-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
and	and	CC	O	O
senna	senna	NN	B-NP	O
tabs	tab	NNS	I-NP	O
2	2	CD	B-NP	O
tablets	tablet	NNS	I-NP	O
twice	twice	RB	B-ADJP	O
daily	daily	RB	I-ADJP	O
to	to	TO	B-VP	O
prevent	prevent	VB	I-VP	O
constipation	constipation	NN	B-NP	O
while	while	IN	B-SBAR	O
on	on	IN	B-PP	O
oxycodone	oxycodone	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

Take	Take	VB	B-VP	O
all	all	DT	B-NP	O
of	of	IN	B-PP	O
your	your	PRP$	B-NP	O
previous	previous	JJ	I-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

Do	Do	VBP	B-VP	O
not	not	RB	I-VP	O
take	take	VB	I-VP	O
ibuprofen	ibuprofen	NN	B-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

For	For	IN	B-PP	O
your	your	PRP$	B-NP	O
urinary	urinary	JJ	I-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
,	,	,	O	O
take	take	VBP	B-VP	O
cefpodoxime	cefpodoxime	NN	B-NP	O
200mg	200mg	NN	I-NP	O
tomorrow	tomorrow	NN	B-NP	O
morning	morning	NN	I-NP	O
and	and	CC	O	O
tomorrow	tomorrow	NN	B-NP	O
night	night	NN	I-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

Dr.	Dr.	NNP	B-NP	O
Zisk	Zisk	NNP	I-NP	O
will	will	MD	B-VP	O
contact	contact	VB	I-VP	O
you	you	PRP	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
date	date	NN	I-NP	O
of	of	IN	B-PP	O
your	your	PRP$	B-NP	O
surgery	surgery	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
also	also	RB	I-VP	O
instruct	instruct	VB	I-VP	O
you	you	PRP	B-NP	O
on	on	IN	B-PP	O
when	when	WRB	B-ADVP	O
to	to	TO	B-VP	O
stop	stop	VB	I-VP	O
taking	take	VBG	I-VP	O
your	your	PRP$	B-NP	O
coumadin	coumadin	NN	I-NP	O
.	.	.	O	O

5	5	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

Come	Come	NNP	B-NP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
experience	experience	VBP	B-VP	O
any	any	DT	B-NP	O
fever	fever	NN	I-NP	O
,	,	,	O	O
worsening	worsen	VBG	B-VP	O
knee	knee	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
inability	inability	NN	B-NP	O
to	to	TO	B-VP	O
ambulate	ambulate	VB	I-VP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

You	You	PRP	B-NP	B-protein
must	must	MD	B-VP	O
wear	wear	VB	I-VP	O
your	your	PRP$	B-NP	O
knee	knee	NN	I-NP	O
immoblizer	immoblizer	NN	I-NP	O
at	at	IN	B-PP	O
all	all	DT	B-NP	O
times	time	NNS	I-NP	O
when	when	WRB	B-ADVP	O
you	you	PRP	B-NP	O
are	be	VBP	B-VP	O
walking	walk	VBG	I-VP	O
.	.	.	O	O

Home	Home	NN	B-NP	O
physical	physical	JJ	I-NP	O
therapy	therapy	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
arranged	arrange	VBN	I-VP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
**	**	SYM	B-NP	O
PCP	PCP	NN	I-NP	B-protein
**	**	SYM	B-NP	I-protein
Monitor	Monitor	NN	I-NP	I-protein
INR	INR	NN	I-NP	I-protein
.	.	.	O	O

Dr.	Dr.	NNP	B-NP	O
Toole	Toole	NNP	I-NP	O
will	will	MD	B-VP	O
notify	notify	VB	I-VP	O
patient	patient	NN	B-NP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
should	should	MD	B-VP	O
stop	stop	VB	I-VP	O
taking	take	VBG	I-VP	O
it	it	PRP	B-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
surgery	surgery	NN	B-NP	O
,	,	,	O	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
SCHWEIM	SCHWEIM	NN	B-NP	O
,	,	,	O	O
THOMAS	THOMAS	NNP	B-NP	O
J	J	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
MN92	MN92	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10/18/06	10/18/06	CD	I-NP	O
@	@	NN	I-NP	O
04	04	CD	I-NP	O
:	:	:	O	O
02	02	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

